BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 22996074)

  • 1. Importance of cytochrome P450 (CYP450) in adverse drug reactions due to drug-drug interactions: a PharmacoVigilance study in France.
    Danton AC; Montastruc F; Sommet A; Durrieu G; Bagheri H; Bondon-Guitton E; Lapeyre-Mestre M; Montastruc JL
    Eur J Clin Pharmacol; 2013 Apr; 69(4):885-8. PubMed ID: 22996074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of drug-drug interactions as a cause of adverse drug reactions: a pharmacovigilance study of serotoninergic reuptake inhibitors in France.
    Montastruc F; Sommet A; Bondon-Guitton E; Durrieu G; Bui E; Bagheri H; Lapeyre-Mestre M; Schmitt L; Montastruc JL
    Eur J Clin Pharmacol; 2012 May; 68(5):767-75. PubMed ID: 22116460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug interactions with cholinesterase inhibitors: an analysis of the French pharmacovigilance database and a comparison of two national drug formularies (Vidal, British National Formulary).
    Tavassoli N; Sommet A; Lapeyre-Mestre M; Bagheri H; Montrastruc JL
    Drug Saf; 2007; 30(11):1063-71. PubMed ID: 17973542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug interactions related to self-medication: a French pharmacovigilance database study.
    Vacher R; Lagarce L; Ghamrawi S; Laugier-Castellan D; Vial T; Bagheri H; Babin M; Briet M
    Fundam Clin Pharmacol; 2020 Oct; 34(5):623-631. PubMed ID: 32064672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bevacizumab-induced serious side-effects: a review of the French pharmacovigilance database.
    Taugourdeau-Raymond S; Rouby F; Default A; Jean-Pastor MJ;
    Eur J Clin Pharmacol; 2012 Jul; 68(7):1103-7. PubMed ID: 22349162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentially inappropriate medications and adverse drug reactions in the elderly: a study in a PharmacoVigilance database.
    Montastruc F; Duguet C; Rousseau V; Bagheri H; Montastruc JL
    Eur J Clin Pharmacol; 2014 Sep; 70(9):1123-7. PubMed ID: 24925091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency and Nature of Adverse Drug Reactions Due to Non-Prescription Drugs in Children: A Retrospective Analysis from the French Pharmacovigilance Database.
    Durrieu G; Maupiler M; Rousseau V; Chebane L; Montastruc F; Bondon-Guitton E; Montastruc JL
    Paediatr Drugs; 2018 Feb; 20(1):81-87. PubMed ID: 28766184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adverse drug reactions in pediatrics: Experience of a regional pharmacovigilance center].
    Saint-Martin C; Kanagaratnam L; de Boissieu P; Azzouz B; Abou Taam M; Trenque T
    Therapie; 2016 Oct; 71(5):467-473. PubMed ID: 27203165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of Nadis(®) software to improve adverse drug reaction reporting of antiretroviral drugs: experience in south west of France (midi-pyrénées)].
    Pochard L; Hauviller L; Cuzin L; Eyvrard F; Sommet A; Montastruc JL; Bagheri H
    Therapie; 2014; 69(2):149-55. PubMed ID: 24926633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug interactions between antihypertensive drugs and non-steroidal anti-inflammatory agents: a descriptive study using the French Pharmacovigilance database.
    Fournier JP; Sommet A; Durrieu G; Poutrain JC; Lapeyre-Mestre M; Montastruc JL;
    Fundam Clin Pharmacol; 2014 Apr; 28(2):230-5. PubMed ID: 23190210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The drugs that mostly frequently induce acute kidney injury: a case - noncase study of a pharmacovigilance database.
    Pierson-Marchandise M; Gras V; Moragny J; Micallef J; Gaboriau L; Picard S; Choukroun G; Masmoudi K; Liabeuf S;
    Br J Clin Pharmacol; 2017 Jun; 83(6):1341-1349. PubMed ID: 28002877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse drug reactions in patients older than 70 years during the heat wave occurred in France in summer 2003: A study from the French PharmacoVigilance Database.
    Michenot F; Sommet A; Bagheri H; Lapeyre-Mestre M; Montastruc JL;
    Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):735-40. PubMed ID: 16924603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paradoxical adverse drug reactions: descriptive analysis of French reports.
    Hakimi Y; Petitpain N; Pinzani V; Montastruc JL; Bagheri H
    Eur J Clin Pharmacol; 2020 Aug; 76(8):1169-1174. PubMed ID: 32418024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse drug reactions to self-medication: a study in a pharmacovigilance database.
    Berreni A; Montastruc F; Bondon-Guitton E; Rousseau V; Abadie D; Durrieu G; Chebane L; Giroud JP; Bagheri H; Montastruc JL
    Fundam Clin Pharmacol; 2015 Oct; 29(5):517-20. PubMed ID: 26215671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proactive Regional Pharmacovigilance System Versus National Spontaneous Reporting for Collecting Safety Data on Concerning Off-Label Prescribing Practices: An Example with Baclofen and Alcohol Dependence in France.
    Auffret M; Labreuche J; Duhamel A; Deheul S; Cottencin O; Bordet R; Gautier S; Rolland B
    Drug Saf; 2017 Mar; 40(3):257-262. PubMed ID: 27988884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The drugs that mostly frequently induce gynecomastia: A national case - noncase study.
    Batteux B; Llopis B; Muller C; Khouri C; Moragny J; Liabeuf S; Masmoudi K; Gras V;
    Therapie; 2020; 75(3):225-238. PubMed ID: 31471065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender differences in adverse drug reactions: analysis of spontaneous reports to a Regional Pharmacovigilance Centre in France.
    Montastruc JL; Lapeyre-Mestre M; Bagheri H; Fooladi A
    Fundam Clin Pharmacol; 2002 Oct; 16(5):343-6. PubMed ID: 12608357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of monitoring adverse drug reactions in elderly patients: the results of a long-term pharmacovigilance programme.
    Carnovale C; Gentili M; Fortino I; Merlino L; Clementi E; Radice S; ViGer Group
    Expert Opin Drug Saf; 2016; 15(2):131-9. PubMed ID: 26882049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal adverse drug reactions: an analysis of reports to the French pharmacovigilance database.
    Kaguelidou F; Beau-Salinas F; Jonville-Bera AP; Jacqz-Aigrain E
    Br J Clin Pharmacol; 2016 Oct; 82(4):1058-68. PubMed ID: 27276109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serious central nervous system side effects of cephalosporins: A national analysis of serious reports registered in the French Pharmacovigilance Database.
    Lacroix C; Kheloufi F; Montastruc F; Bennis Y; Pizzoglio V; Micallef J
    J Neurol Sci; 2019 Mar; 398():196-201. PubMed ID: 30683462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.